1. Home
  2. NPKI vs TBPH Comparison

NPKI vs TBPH Comparison

Compare NPKI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc. Common Stock

NPKI

NPK International Inc. Common Stock

HOLD

Current Price

$12.92

Market Cap

973.4M

Sector

Industrials

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.73

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
TBPH
Founded
1932
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.4M
993.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NPKI
TBPH
Price
$12.92
$18.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$14.17
$27.80
AVG Volume (30 Days)
766.9K
601.0K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
0.58
Revenue
$259,372,000.00
$80,327,000.00
Revenue This Year
$21.14
$70.78
Revenue Next Year
$9.42
N/A
P/E Ratio
$34.16
$32.19
Revenue Growth
25.65
27.12
52 Week Low
$4.76
$7.90
52 Week High
$14.00
$20.33

Technical Indicators

Market Signals
Indicator
NPKI
TBPH
Relative Strength Index (RSI) 61.20 58.73
Support Level $11.17 $18.39
Resistance Level $12.62 $20.32
Average True Range (ATR) 0.46 0.87
MACD 0.07 -0.05
Stochastic Oscillator 98.45 53.71

Price Performance

Historical Comparison
NPKI
TBPH

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: